Overview

Tolerance and Pharmacokinetics of TQ-B3233

Status:
Unknown status
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
Study of Tolerance and Pharmacokinetics of TQ-B3233 Capsule, phase I,single arm.
Phase:
Phase 1
Details
Lead Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd